OTC Markets OTCPK - Delayed Quote USD

Fresenius Medical Care AG (FMCQF)

42.37 -1.45 (-3.31%)

As of October 30 at 4:00:00 PM EDT. Market Open.

FMS Launches multiFiltratePRO System for U.S. Patients With Acute AKI

Zacks 10d ago

FMS

ISRG

OPK
Fresenius Medical Care Brings Kidney Care Innovation to Critical Care Patients with U.S. Launch of multiFiltratePRO™

PR Newswire 11d ago

FMS
Fresenius Medical Care presents new evidence and innovations advancing kidney care at ASN Kidney Week 2026

PR Newswire 14d ago

FMS

FME
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now

Zacks 26d ago

GMED

FMS

WST
Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth

PR Newswire 26d ago

FMS
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading

PREMIUM
MT Newswires 1mo ago

ASML

NOK

FMS
Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth

Zacks 1mo ago

FMS

ISRG

GMED
Fresenius Medical Care Refines China Commercial Strategy with a Focus on Long-Term Growth and Market Leadership

PR Newswire 1mo ago

FMS
FDA Slams Fresenius Over Leaking Dialysis Bags, Warns of Potentially Life-Threatening Risk

Benzinga 1mo ago

FMS
Can Fresenius Medical's 5008X Rollout Drive the Next Growth Phase?

Zacks 1mo ago

FMS

DVA

OM
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now

Zacks 1mo ago

FMS

^GSPC

VCYT
Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis

PR Newswire 2mo ago

FMS

FME

U.S. markets closed

Fresenius Medical Care AG (FMCQF)

FMS Launches multiFiltratePRO System for U.S. Patients With Acute AKI

Fresenius Medical Care Brings Kidney Care Innovation to Critical Care Patients with U.S. Launch of multiFiltratePRO™

Fresenius Medical Care presents new evidence and innovations advancing kidney care at ASN Kidney Week 2026

Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now

Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth

European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading

Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth

Fresenius Medical Care Refines China Commercial Strategy with a Focus on Long-Term Growth and Market Leadership

FDA Slams Fresenius Over Leaking Dialysis Bags, Warns of Potentially Life-Threatening Risk

Can Fresenius Medical's 5008X Rollout Drive the Next Growth Phase?

Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now

Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis